Brief: Inhibikase Therapeutics Receives Grant From U.S. National Institutes Of Health To Evaluate IkT-148009 For The Treatment Of Multiple System Atrophy
23/09/2021 13:13
Sept 23 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* INHIBIKASE THERAPEUTICS RECEIVES GRANT FROM U.S. NATIONAL
INSTITUTES OF HEALTH TO EVALUATE IKT-148009 FOR THE TREATMENT OF
MULTIPLE SYSTEM ATROPHY
Source text for Eikon: ID:nPn8zHjYKa
Further company coverage: IKT.O
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary